IP Group PLC
LSE:IPO
Intrinsic Value
IP Group Plc engages in commercializing intellectual properties mainly from its partner universities. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of IPO.
Fundamental Analysis
Balance Sheet Decomposition
IP Group PLC
Current Assets | 236.5m |
Cash & Short-Term Investments | 226.9m |
Receivables | 9.6m |
Non-Current Assets | 1.2B |
Long-Term Investments | 1.2B |
PP&E | 1.4m |
Intangibles | 400k |
Other Non-Current Assets | 7.8m |
Current Liabilities | 23.4m |
Accounts Payable | 17.1m |
Other Current Liabilities | 6.3m |
Non-Current Liabilities | 188.8m |
Long-Term Debt | 148.7m |
Other Non-Current Liabilities | 40.1m |
Earnings Waterfall
IP Group PLC
Revenue
|
-4.9m
GBP
|
Operating Expenses
|
-25.9m
GBP
|
Operating Income
|
-30.8m
GBP
|
Other Expenses
|
-140.5m
GBP
|
Net Income
|
-171.3m
GBP
|
Free Cash Flow Analysis
IP Group PLC
IPO Profitability Score
Profitability Due Diligence
IP Group PLC's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
IP Group PLC's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
IPO Solvency Score
Solvency Due Diligence
IP Group PLC's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
IP Group PLC's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IPO Price Targets Summary
IP Group PLC
According to Wall Street analysts, the average 1-year price target for IPO is 130.56 GBX with a low forecast of 127.26 GBX and a high forecast of 136.5 GBX.
Shareholder Return
IPO Price
IP Group PLC
Average Annual Return | -4.24% |
Standard Deviation of Annual Returns | 39.75% |
Max Drawdown | -71% |
Market Capitalization | 494m GBX |
Shares Outstanding | 1 035 891 300 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
IP Group Plc engages in commercializing intellectual properties mainly from its partner universities. The firm's segments include University partnership business and Venture capital fund management. The University partnership business segment is engaged in the commercialization of intellectual property through the formation of long-term partner relationships with universities. The Venture capital fund management segment is engaged in the management of venture funds focusing on the United Kingdom's early-stage technology companies and the provision of corporate finance advice. The firm's life sciences portfolio comprises holdings in approximately 38 companies. Its technology portfolio comprises holdings in approximately 44 companies. The company has three areas of geographic focus, which includes the United Kingdom, the United States, Australia and New Zealand.